These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 16020101

  • 1. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G, Terenziani M, Polastri D, Bellani FF, Mazzaferro V.
    Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
    [Abstract] [Full Text] [Related]

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J, Bode U, von Schweinitz D, Weinel P, Erttmann R, Harms D, Mildenberger H.
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [Abstract] [Full Text] [Related]

  • 5. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, Roebuck D, Childs M, Zimmermann A, Laithier V, Otte JB, de Camargo B, MacKinlay G, Scopinaro M, Aronson D, Plaschkes J, Perilongo G.
    J Clin Oncol; 2010 May 20; 28(15):2584-90. PubMed ID: 20406943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A, Blanchard H, Champagne J, St-Vil D, Bensoussan AL.
    J Pediatr Surg; 2001 May 20; 36(5):755-9. PubMed ID: 11329582
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
    Lee JL, Ryu MH, Chang HM, Kim TW, Lee SS, Sym SJ, Kim MK, Kim KM, Lee JS, Kang YK.
    J Gastroenterol Hepatol; 2008 May 20; 23(5):811-6. PubMed ID: 17995941
    [Abstract] [Full Text] [Related]

  • 9. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D, Bürger D, Bode U, Weinel P, Erttmann R, Hecker H, Mildenberger H.
    Klin Padiatr; 1994 May 20; 206(4):282-8. PubMed ID: 7526028
    [Abstract] [Full Text] [Related]

  • 10. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
    Tarusawa K, Yodono H, Ikami I, Sasaki T, Kanehira J, Takahashi S, Shibutani K, Noda H, Shinohara A, Takekawa D.
    Gan To Kagaku Ryoho; 1992 Mar 20; 19(3):383-6. PubMed ID: 1311915
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D, Bürger D, Weinel P, Mildenberger H.
    Klin Padiatr; 1992 Mar 20; 204(4):214-20. PubMed ID: 1381454
    [Abstract] [Full Text] [Related]

  • 12. Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment.
    Czauderna P.
    Med Pediatr Oncol; 2002 Nov 20; 39(5):519-23. PubMed ID: 12228910
    [Abstract] [Full Text] [Related]

  • 13. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, Pietsch JB.
    J Pediatr Surg; 2006 Jan 20; 41(1):182-6. PubMed ID: 16410130
    [Abstract] [Full Text] [Related]

  • 14. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP.
    J Clin Oncol; 2006 Jun 20; 24(18):2879-84. PubMed ID: 16782927
    [Abstract] [Full Text] [Related]

  • 15. [Hepatic arterial infusion chemotherapy using totally implantable port system].
    Takayasu Y, Yamamoto S, Ikeda J.
    Gan To Kagaku Ryoho; 2000 Sep 20; 27(10):1516-20. PubMed ID: 11015995
    [Abstract] [Full Text] [Related]

  • 16. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
    Boucher E, Corbinais S, Brissot P, Boudjema K, Raoul JL.
    Cancer Chemother Pharmacol; 2002 Oct 20; 50(4):305-8. PubMed ID: 12357305
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, de Camargo B, Zsiros J, Roebuck D, Zimmermann A, Aronson D, Childs M, Widing E, Laithier V, Plaschkes J, Pritchard J, Scopinaro M, MacKinlay G, Czauderna P.
    N Engl J Med; 2009 Oct 22; 361(17):1662-70. PubMed ID: 19846851
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
    Pan C, Tang JY, Chen J, Xue HL, Dong L, Zhou M, Jiang H, Ye QD, Gu LJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug 22; 11(8):659-62. PubMed ID: 19695195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.